Structure-activity relationship of rubiscolins as δ opioid peptidesSHUZHANG YANG; SONODA, Soushi; LIPING CHEN et al.Peptides (New York, NY. 1980). 2003, Vol 24, Num 4, pp 503-508, issn 0196-9781, 6 p.Article

Increased affinity and selectivity of enkephalin tripeptide (Tyr-D-Ala-Gly) dimersLUTZ, R. A; CRUCIANI, R. A; SHIMOHIGASHI, Y et al.European journal of pharmacology. 1985, Vol 111, Num 2, pp 257-261, issn 0014-2999Article

Enkephalin degradation by enkephalinergic neuroblastoma cells: involvement of angiotensin-converting-enzymePALENKER, J; LENTZEN, H; BRANDT, U et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 325, Num 3, pp 214-217, issn 0028-1298Article

Effects of β-endorphin fragment 6-31 on morphine- and β-endorphin-induced growth hormone and prolactin releasePANERAI, A. E; COCCHI, D; PARENTI, M et al.European journal of pharmacology. 1984, Vol 99, Num 4, pp 341-343, issn 0014-2999Article

National Trends in the Office-Based Prescription of Schedule II OpioidsOLFSON, Mark; SHUAI WANG; IZA, Miren et al.The Journal of clinical psychiatry. 2013, Vol 74, Num 9, pp 933-940, issn 0160-6689, 8 p.Article

Dexamethasone increases both catecholamines and methionine-enkephalin in cultured bovine adrenal chromaffin cells and human extramedullary pheochromocytoma cellsYANASE, T; NAWATA, H; HIGUCHI, K et al.Life sciences (1973). 1984, Vol 35, Num 18, pp 1869-1875, issn 0024-3205Article

Opioid peptides and self-stimulation of the medial prefrontal cortex in the ratSHAW, S. G; VIVES, F; MORA, F et al.Psychopharmacologia. 1984, Vol 83, Num 3, pp 288-292, issn 0033-3158Article

Deficit in beta-endorphin peptide and tendency to alcohol abuseZALEWSKA-KASZUBSKA, Jadwiga; CZARNECKA, Elzbieta.Peptides (New York, NY. 1980). 2005, Vol 26, Num 4, pp 701-705, issn 0196-9781, 5 p.Article

Nouveaux analgésiques par complète inhibition de la dégradation enzymatique des opioïdes endogènes = New painkillers inhibiting the physiological breakdown of endogenous opioidsROQUES, Bernard P; FOURNIE-ZALUSKI, Marie-Claude; WURM, Michel et al.MS. Médecine sciences. 2012, Vol 28, Num 5, pp 476-478, issn 0767-0974, 3 p.Article

[Dmt¹, D-1-Nal³]morphiceptin, a novel opioid peptide analog with high analgesic activityFICHNA, Jakub; DO-REGO, Jean-Claude; CHUNG, Nga N et al.Peptides (New York, NY. 1980). 2008, Vol 29, Num 4, pp 633-638, issn 0196-9781, 6 p.Article

Novel opioid peptides derived from mitochondrial cytochrome b: cytochrophinsBRANTL, V; GRAMSCH, C; LOTTSPEICH, F et al.European journal of pharmacology. 1985, Vol 111, Num 2, pp 293-294, issn 0014-2999Article

Human leumorphin is a potent, kappa opioid receptor agonistSUDA, M; NAKAO, K; YOSHIMASA, T et al.Neuroscience letters. 1984, Vol 50, Num 1-3, pp 49-52, issn 0304-3940Article

Effect of intrahypothalamic injection of [D-Ala²,D-Leu⁵]enkephalin on feeding and temperature in the ratTEPPERMAN, F. S; HIRST, M.European journal of pharmacology. 1983, Vol 96, Num 3-4, pp 243-249, issn 0014-2999Article

Estimating the prevalence of opioid dependenceHARTNOLL, R; LEWIS, R; MITCHESON, M et al.Lancet (British edition). 1985, Num 8422, pp 203-205, issn 0140-6736Article

Species differences in the relative analgesic potencies of some classical opiates and opioid peptidesSZEKELY, J. I; MIGLECZ, E; BAJUSZ, S et al.Psychopharmacologia. 1984, Vol 82, Num 4, pp 400-402, issn 0033-3158Article

Endogenous opiates and behavior: 2003BODNAR, Richard J; KLEIN, Gad E.Peptides (New York, NY. 1980). 2004, Vol 25, Num 12, pp 2205-2256, issn 0196-9781, 52 p.Article

Kinetic of in vitro generation of some hemorphins : early release of LVV-hemorphin-7, precursor of VV-hemorphin-7DAGOUASSAT, N; GARREAU, I; ZHAO, Q et al.Neuropeptides (Edinburgh). 1996, Vol 30, Num 1, pp 1-5, issn 0143-4179Article

Synthesis of radioiodinated naltrindole analogues: ligands for studies of delta opioid receptorsKINTER, C. M; LEVER, J. R.Nuclear medicine and biology. 1995, Vol 22, Num 5, pp 599-606, issn 0969-8051Article

Dysregulation of Regional Endogenous Opioid Function in Borderline Personality DisorderPROSSIN, Alan R; LOVE, Tiffany M; KOEPPE, Robert A et al.The American journal of psychiatry. 2010, Vol 167, Num 8, pp 925-933, issn 0002-953X, 9 p.Article

Pharmacologically selective block of mu opioid antinociception by peptide nucleic acid antisense in absence of detectable ex vivo knockdownPRADHAN, Amynah A. A; CLARKE, Paul B. S.European journal of pharmacology. 2005, Vol 506, Num 3, pp 229-236, issn 0014-2999, 8 p.Article

Synthesis and binding characteristics of a novel enkephalin analogue, [³h]Tyr-D-Ala-Gly-Phe-D-Nle-Arg-PheTOTH, Fanni; FARKAS, Judit; TOTH, Géza et al.Peptides (New York, NY. 1980). 2003, Vol 24, Num 9, pp 1433-1440, issn 0196-9781, 8 p.Article

Effects of neuroleptic treatments on peripheral opioid secretionBRAMBILLA, F; FACCHINETTI, F; PETRAGLIA, F et al.Neuropsychobiology. 1987, Vol 18, Num 2, pp 68-73, issn 0302-282XArticle

Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II: Involvement of the mesolimbic dopamine systemKALIVAS, P. W.The Journal of pharmacology and experimental therapeutics. 1985, Vol 235, Num 2, pp 544-550, issn 0022-3565Article

Effect of bestatin and thiorphan on [Met⁵]enkephalin-Arg⁶-Phe⁷-induced analgesiaREGGIANI, A; CARENZI, A; FRIGENI, V et al.European journal of pharmacology. 1984, Vol 105, Num 3-4, pp 361-364, issn 0014-2999Article

Enkephalin heptapeptide (Tyr-Gly-Phe-Met-Arg-Phe)-induced bronchospasm in Guinea pigs: a non-naloxone reversible phenomenonCHIPKIN, R. E; CHAPMAN, R. W.Life sciences (1973). 1984, Vol 34, Num 19, pp 1809-1817, issn 0024-3205Article